Cargando…
Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells
Sphingosylphosphorylcholine (SPC) induces differentiation of human adipose tissue-derived mesenchymal stem cells (hASCs) into smooth muscle-like cells expressing α-smooth muscle actin (α-SMA) via transforming growth factor-β1/Smad2- and RhoA/Rho kinase-dependent mechanisms. 3-Hydroxy-3-methylglutary...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296812/ https://www.ncbi.nlm.nih.gov/pubmed/22127053 http://dx.doi.org/10.3858/emm.2012.44.2.011 |
_version_ | 1782225797568790528 |
---|---|
author | Kim, Kyung Hye Kim, Young Mi Lee, Mi Jeong Ko, Hyun-Chang Kim, Moon-Bum Kim, Jae Ho |
author_facet | Kim, Kyung Hye Kim, Young Mi Lee, Mi Jeong Ko, Hyun-Chang Kim, Moon-Bum Kim, Jae Ho |
author_sort | Kim, Kyung Hye |
collection | PubMed |
description | Sphingosylphosphorylcholine (SPC) induces differentiation of human adipose tissue-derived mesenchymal stem cells (hASCs) into smooth muscle-like cells expressing α-smooth muscle actin (α-SMA) via transforming growth factor-β1/Smad2- and RhoA/Rho kinase-dependent mechanisms. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) have been known to have beneficial effects in the treatment of cardiovascular diseases. In the present study, we examined the effects of simvastatin on the SPC-induced α-SMA expression and Smad2 phosphorylation in hASCs. Simvastatin inhibited the SPC-induced α-SMA expression and sustained phosphorylation of Smad2 in hASCs. SPC treatment caused RhoA activation via a simvastatin-sensitive mechanism. The SPC-induced α-SMA expression and Smad2 phosphorylation were abrogated by pretreatment of the cells with the Rho kinase inhibitor Y27632 or overexpression of a dominant negative RhoA mutant. Furthermore, SPC induced secretion of TGF-β1 and pretreatment with either Y27632 or simvastatin inhibited the SPC-induced TGF-β1 secretion. These results suggest that simvastatin inhibits SPC-induced differentiation of hASCs into smooth muscle cells by attenuating the RhoA/Rho kinase-dependent activation of autocrine TGF-β1/Smad2 signaling pathway. |
format | Online Article Text |
id | pubmed-3296812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Korean Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-32968122012-03-12 Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells Kim, Kyung Hye Kim, Young Mi Lee, Mi Jeong Ko, Hyun-Chang Kim, Moon-Bum Kim, Jae Ho Exp Mol Med Original Article Sphingosylphosphorylcholine (SPC) induces differentiation of human adipose tissue-derived mesenchymal stem cells (hASCs) into smooth muscle-like cells expressing α-smooth muscle actin (α-SMA) via transforming growth factor-β1/Smad2- and RhoA/Rho kinase-dependent mechanisms. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) have been known to have beneficial effects in the treatment of cardiovascular diseases. In the present study, we examined the effects of simvastatin on the SPC-induced α-SMA expression and Smad2 phosphorylation in hASCs. Simvastatin inhibited the SPC-induced α-SMA expression and sustained phosphorylation of Smad2 in hASCs. SPC treatment caused RhoA activation via a simvastatin-sensitive mechanism. The SPC-induced α-SMA expression and Smad2 phosphorylation were abrogated by pretreatment of the cells with the Rho kinase inhibitor Y27632 or overexpression of a dominant negative RhoA mutant. Furthermore, SPC induced secretion of TGF-β1 and pretreatment with either Y27632 or simvastatin inhibited the SPC-induced TGF-β1 secretion. These results suggest that simvastatin inhibits SPC-induced differentiation of hASCs into smooth muscle cells by attenuating the RhoA/Rho kinase-dependent activation of autocrine TGF-β1/Smad2 signaling pathway. Korean Society for Biochemistry and Molecular Biology 2012-02-29 2011-11-30 /pmc/articles/PMC3296812/ /pubmed/22127053 http://dx.doi.org/10.3858/emm.2012.44.2.011 Text en Copyright © 2012 by The Korean Society for Biochemistry and Molecular Biology http://creativecommons.org/licenses/by-nc/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kim, Kyung Hye Kim, Young Mi Lee, Mi Jeong Ko, Hyun-Chang Kim, Moon-Bum Kim, Jae Ho Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells |
title | Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells |
title_full | Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells |
title_fullStr | Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells |
title_full_unstemmed | Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells |
title_short | Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells |
title_sort | simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296812/ https://www.ncbi.nlm.nih.gov/pubmed/22127053 http://dx.doi.org/10.3858/emm.2012.44.2.011 |
work_keys_str_mv | AT kimkyunghye simvastatininhibitssphingosylphosphorylcholineinduceddifferentiationofhumanmesenchymalstemcellsintosmoothmusclecells AT kimyoungmi simvastatininhibitssphingosylphosphorylcholineinduceddifferentiationofhumanmesenchymalstemcellsintosmoothmusclecells AT leemijeong simvastatininhibitssphingosylphosphorylcholineinduceddifferentiationofhumanmesenchymalstemcellsintosmoothmusclecells AT kohyunchang simvastatininhibitssphingosylphosphorylcholineinduceddifferentiationofhumanmesenchymalstemcellsintosmoothmusclecells AT kimmoonbum simvastatininhibitssphingosylphosphorylcholineinduceddifferentiationofhumanmesenchymalstemcellsintosmoothmusclecells AT kimjaeho simvastatininhibitssphingosylphosphorylcholineinduceddifferentiationofhumanmesenchymalstemcellsintosmoothmusclecells |